Azora Therapeutics, Inc. (DE) SEC filings ADIL
Azora Therapeutics, Inc. (DE) has 575 filings in SEC EDGAR's recent list, going back to Mar 16, 2011. Its latest annual report, Form ARS, was filed on Aug 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (officer or director change, bylaw or fiscal year change, shareholder vote results, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Nov 4, 2026 | Nov 2, 2026 |
| 4 | Insider transaction | Nov 4, 2026 | Nov 2, 2026 |
| 4 | Insider transaction | Nov 3, 2026 | Nov 2, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 3, 2026 | — |
| 4 | Insider transaction | Oct 30, 2026 | Oct 28, 2026 |
| 3 | Initial insider ownership | Oct 30, 2026 | Oct 28, 2026 |
| 3 | Initial insider ownership | Oct 30, 2026 | Oct 28, 2026 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
|
Oct 28, 2026 | Oct 28, 2026 |
| EFFECT | Filing | Oct 26, 2026 | — |
| 10-Q/A | Amended quarterly report | Oct 21, 2026 | Jun 30, 2026 |
| S-3/A | Amendment no. 1 to form s-3 | Oct 21, 2026 | — |
| DEFA14A | Additional proxy material | Oct 16, 2026 | — |
| 8-K |
Current report
Other events
|
Oct 16, 2026 | Oct 15, 2026 |
| DEFA14A | Additional proxy material | Oct 5, 2026 | — |
| 8-K |
Current report
Other events
|
Oct 2, 2026 | Oct 1, 2026 |
| 4 | Insider transaction | Sep 21, 2026 | Sep 17, 2026 |
| DEFA14A | Additional proxy material | Sep 18, 2026 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Sep 18, 2026 | Sep 17, 2026 |
| DEFA14A | Additional proxy material | Sep 16, 2026 | — |
| 8-K |
Current report
Material agreement, Other events
|
Sep 16, 2026 | Sep 16, 2026 |
| S-3 | Shelf registration | Aug 28, 2026 | — |
| S-8 | Employee stock plan registration | Aug 28, 2026 | — |
| 8-K |
Current report
Unregistered share sale
|
Aug 25, 2026 | Aug 19, 2026 |
| ARS | Annual report to shareholders | Aug 24, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Aug 24, 2026 | Sep 17, 2026 |
| 8-K |
Current report
Listing notice
|
Aug 21, 2026 | Aug 18, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 17, 2026 | Aug 17, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Officer or director change, Other events
|
Aug 13, 2026 | Aug 10, 2026 |
| PRE 14A | Preliminary proxy statement | Aug 11, 2026 | Aug 10, 2026 |
| 8-K/A | Amended current report | Aug 11, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jul 16, 2026 | Jul 14, 2026 |
| 4 | Insider transaction | Jul 13, 2026 | Jul 9, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 1, 2026 | — |
| 4 | Insider transaction | Jul 1, 2026 | Jun 29, 2026 |
| 3 | Initial insider ownership | Jun 29, 2026 | Jun 24, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 24, 2026 | — |
| 4 | Insider transaction | Jun 16, 2026 | Jun 11, 2026 |
| 3 | Initial insider ownership | Jun 16, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jun 16, 2026 | Jun 12, 2026 |
| 3 | Initial insider ownership | Jun 16, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, New debt, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Jun 11, 2026 | Jun 11, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| 8-K |
Current report
Results of operations
|
May 11, 2026 | May 11, 2026 |
| 10-Q | Quarterly report | May 8, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 9, 2026 | Apr 7, 2026 |
| 4 | Insider transaction | Apr 9, 2026 | Apr 7, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 9, 2026 | Apr 7, 2026 |
| 4 | Insider transaction | Apr 9, 2026 | Apr 7, 2026 |
| 4 | Insider transaction | Apr 9, 2026 | Apr 7, 2026 |
| 4 | Insider transaction | Apr 9, 2026 | Apr 7, 2026 |
| 4 | Insider transaction | Apr 9, 2026 | Apr 7, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 6, 2026 | Mar 6, 2026 |
| 10-K | Annual report | Mar 5, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 3, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Other events
|
Feb 24, 2026 | Feb 23, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 18, 2026 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Feb 4, 2026 | Feb 3, 2026 |
| 8-K |
Current report
Officer or director change
|
Jan 6, 2026 | Jan 5, 2026 |
| DEF 14A | Proxy statement | Jan 6, 2026 | Feb 26, 2026 |
| PRE 14A | Preliminary proxy statement | Dec 23, 2025 | Dec 23, 2025 |
| 424B5 | Prospectus supplement | Dec 19, 2025 | — |
| EFFECT | Filing | Dec 17, 2025 | — |
| CORRESP | Letter to the SEC | Dec 15, 2025 | — |
| S-3 | Shelf registration | Dec 12, 2025 | — |
| D | Filing | Dec 3, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Dec 1, 2025 | Nov 25, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2025 | Nov 14, 2025 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 16, 2025 | Sep 16, 2025 |
| S-8 | Employee stock plan registration | Sep 9, 2025 | — |
| 8-K |
Current report
Listing notice
|
Sep 3, 2025 | Sep 2, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2025 | Aug 14, 2025 |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 424B5 | Prospectus supplement | Aug 1, 2025 | — |
| 8-K |
Current report
Material agreement, Agreement ended
|
Aug 1, 2025 | Jul 31, 2025 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Aug 1, 2025 | Aug 1, 2025 |
| 424B5 | Prospectus supplement | Jul 31, 2025 | — |
| 8-K |
Current report
Other events
|
Jul 16, 2025 | Jul 14, 2025 |
| 8-K |
Current report
Other events
|
Jul 10, 2025 | Jul 9, 2025 |
| DEFR14A | Proxy statement | Jun 27, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 23, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Jun 18, 2025 | Jun 16, 2025 |
| 424B5 | Prospectus supplement | Jun 18, 2025 | — |
| PRER14A | Proxy statement | Jun 17, 2025 | — |
| EFFECT | Filing | Jun 16, 2025 | — |
| 8-K |
Current report
Other events
|
Jun 16, 2025 | Jun 16, 2025 |
| S-1/A | Amended registration statement | Jun 13, 2025 | — |
| CORRESP | Letter to the SEC | Jun 12, 2025 | — |
| CORRESP | Letter to the SEC | Jun 12, 2025 | — |
| ARS | Annual report to shareholders | Jun 10, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Jun 10, 2025 | Jul 24, 2025 |
| 424B3 | Prospectus | Jun 10, 2025 | — |
| EFFECT | Filing | Jun 9, 2025 | — |
| CORRESP | Letter to the SEC | Jun 6, 2025 | — |
| S-1 | Registration statement | Jun 6, 2025 | — |
| CORRESP | Letter to the SEC | Jun 5, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 4, 2025 | — |
| 4 | Insider transaction | Jun 2, 2025 | May 29, 2025 |
| 4 | Insider transaction | Jun 2, 2025 | May 29, 2025 |
| 4 | Insider transaction | Jun 2, 2025 | May 29, 2025 |
| 4 | Insider transaction | Jun 2, 2025 | May 29, 2025 |
| 4 | Insider transaction | Jun 2, 2025 | May 29, 2025 |
| 4 | Insider transaction | Jun 2, 2025 | May 29, 2025 |
| 4 | Insider transaction | Jun 2, 2025 | May 29, 2025 |
| S-3 | Shelf registration | May 30, 2025 | — |
| 8-K |
Current report
Listing notice
|
May 30, 2025 | May 23, 2025 |
| PRE 14A | Preliminary proxy statement | May 23, 2025 | May 23, 2025 |
| 8-K |
Current report
Other events
|
May 15, 2025 | May 14, 2025 |
| 8-K |
Current report
Results of operations
|
May 15, 2025 | May 15, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| D | Filing | May 14, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
May 7, 2025 | May 2, 2025 |
| 424B5 | Prospectus supplement | May 2, 2025 | — |
| 424B5 | Prospectus supplement | May 2, 2025 | — |
| 8-K |
Current report
Auditor change
|
May 1, 2025 | Apr 28, 2025 |
| UPLOAD | Letter from the SEC | Apr 1, 2025 | — |
| DRSLTR | Filing | Mar 27, 2025 | — |
| DRS | Filing | Mar 27, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Mar 21, 2025 | Mar 20, 2025 |
| 8-K |
Current report
Listing notice
|
Mar 7, 2025 | Mar 5, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 4, 2025 | Mar 4, 2025 |
| 10-K | Annual report | Mar 4, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 25, 2025 | Feb 25, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2025 | Jan 8, 2025 |
| 424B3 | Prospectus | Dec 31, 2024 | — |
| EFFECT | Filing | Dec 30, 2024 | — |
| CORRESP | Letter to the SEC | Dec 26, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 26, 2024 | — |
| S-1 | Registration statement | Dec 20, 2024 | — |
| 8-K |
Current report
Material agreement, Agreement ended, Unregistered share sale
|
Dec 18, 2024 | Dec 13, 2024 |
| S-8 | Employee stock plan registration | Dec 12, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Dec 6, 2024 | Dec 5, 2024 |
| 4 | Insider transaction | Dec 5, 2024 | Dec 5, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 18, 2024 | Nov 14, 2024 |
| 4 | Insider transaction | Nov 18, 2024 | Nov 16, 2024 |
| 3 | Initial insider ownership | Nov 18, 2024 | Nov 16, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Officer or director change
|
Nov 5, 2024 | Nov 1, 2024 |
| ARS | Annual report to shareholders | Sep 30, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Sep 27, 2024 | Nov 12, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 26, 2024 | Apr 24, 2024 |
| 424B3 | Prospectus | Apr 23, 2024 | — |
| EFFECT | Filing | Apr 19, 2024 | — |
| 424B5 | Prospectus supplement | Apr 18, 2024 | — |
| 8-K |
Current report
Material agreement
|
Apr 18, 2024 | Apr 18, 2024 |
| CORRESP | Letter to the SEC | Apr 17, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 17, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Apr 16, 2024 | Apr 10, 2024 |
| S-3 | Shelf registration | Apr 12, 2024 | — |
| 10-K | Annual report | Apr 1, 2024 | Dec 31, 2023 |
| 4 | Insider transaction | Mar 27, 2024 | Mar 25, 2024 |
| 4 | Insider transaction | Mar 27, 2024 | Mar 25, 2024 |
| 4 | Insider transaction | Mar 27, 2024 | Mar 25, 2024 |
| 4 | Insider transaction | Mar 27, 2024 | Mar 25, 2024 |
| 4 | Insider transaction | Mar 27, 2024 | Mar 25, 2024 |
| 4 | Insider transaction | Mar 27, 2024 | Mar 25, 2024 |
| 4 | Insider transaction | Mar 27, 2024 | Mar 25, 2024 |
| D | Filing | Mar 14, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Mar 6, 2024 | Mar 1, 2024 |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| 424B5 | Prospectus supplement | Jan 25, 2024 | — |
| EFFECT | Filing | Jan 24, 2024 | — |
| CORRESP | Letter to the SEC | Jan 22, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 19, 2024 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 18, 2024 | Jan 17, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jan 16, 2024 | Jan 11, 2024 |
| S-3 | Shelf registration | Jan 12, 2024 | — |
| DEFA14A | Additional proxy material | Dec 15, 2023 | — |
| S-8 | Employee stock plan registration | Dec 12, 2023 | — |
| DEF 14A | Proxy statement | Dec 8, 2023 | Jan 11, 2024 |
| 8-K |
Current report
Listing notice
|
Nov 29, 2023 | Nov 29, 2023 |
| 8-K |
Current report
Listing notice
|
Nov 28, 2023 | Nov 21, 2023 |
| PRE 14A | Preliminary proxy statement | Nov 24, 2023 | Nov 24, 2023 |
| 424B3 | Prospectus | Nov 20, 2023 | — |
| EFFECT | Filing | Nov 16, 2023 | — |
| CORRESP | Letter to the SEC | Nov 15, 2023 | — |
| 8-K |
Current report
Results of operations
|
Nov 14, 2023 | Nov 14, 2023 |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| UPLOAD | Letter from the SEC | Nov 14, 2023 | — |
| S-1 | Registration statement | Nov 8, 2023 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Nov 6, 2023 | Nov 2, 2023 |
| 10-Q/A | Amended quarterly report | Oct 30, 2023 | Jun 30, 2023 |
| 8-K/A |
Amended current report
Acquisition or sale of assets
|
Oct 30, 2023 | Aug 17, 2023 |
| NT 10-Q/A | Amendment no. 1 notification of late filing | Oct 30, 2023 | Jun 30, 2023 |
| D | Filing | Oct 26, 2023 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Oct 24, 2023 | Oct 19, 2023 |
| 4 | Insider transaction | Oct 3, 2023 | Sep 29, 2023 |
| ARS | Annual report to shareholders | Oct 2, 2023 | Dec 31, 2022 |
| DEF 14A | Proxy statement | Oct 2, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Other events
|
Sep 27, 2023 | Sep 26, 2023 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Sep 21, 2023 | Sep 18, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 11, 2023 | Sep 11, 2023 |
| 8-K |
Current report
Listing notice
|
Aug 23, 2023 | Aug 21, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 21, 2023 | Aug 21, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AZR (Nasdaq), ADIL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Encino, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1513525
- Former names
- ADIAL PHARMACEUTICALS, INC. (until Oct 30, 2026); Adial Pharmaceuticals, L.L.C. (until Sep 28, 2017); ADial Pharmaceuticals, L.L.C. (until Sep 28, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.